Bone Biologics Corp
BBLG- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001419554
No open-market purchases or sales by Bone Biologics Corp insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $35.7K in total; no superinvestor holds it.
Other share classesBBLGW
Q3 2023 vs. Q2 2023
How the institutions holding Bone Biologics Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 7 | 8 | +1 |
| Shares | 404.8K | 330.6K | −74.2K (−18.3%) |
| Value | $576.4K | $235.1K | −$341.2K (−59.2%) |
New holders (4)
Institutions that held Bone Biologics Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 16,013 | $11.4K | 0.00% |
| MML Investors Services, LLC | 15,000 | $11.0K | 0.00% |
| Citadel Advisors LLC | 11,335 | $8.05K | 0.00% |
| UBS Group AG | 135 | $96 | 0.00% |
Sold out (3)
Institutions that held Bone Biologics Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Kepos Capital LP | 50,000 | $72.0K |
| Warberg Asset Management LLC | 27,000 | $38.3K |
| Sabby Management, LLC | 10,817 | $15.5K |